(Press-News.org)
“[...] we found no impact of the addition of metformin to [androgen deprivation] therapy on risk of metabolic syndrome associated with castration therapy and no additional anti-tumor effects.”
BUFFALO, NY- June 20, 2023 – A new research paper was published in Oncotarget's Volume 14 on June 19, 2023, entitled, “Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.”
Androgen deprivation therapy (ADT) can lead to metabolic syndrome (MS) and is implicated in ADT-resistance. Metformin showed antineoplastic activity through mTOR inhibition secondary AMPK-activation.
To investigate whether metformin mitigated ADT-related MS, researchers Devalingam Mahalingam, Salih Hanni, Anthony V. Serritella, Christos Fountzilas, Joel Michalek, Brian Hernandez, John Sarantopoulos, Paromitta Datta, Ofelia Romero, Sureshkumar Mulampurath Achutan Pillai, John Kuhn, Michael Pollak6, and Ian M. Thompson from the University of Texas Health Science Center, Robert H Lurie Comprehensive Cancer Center of Northwestern University, Roswell Park Cancer Institute, Mays Cancer Center at University of Texas Health, Audie Murphy VA Hospital, McGill University, and Christus Health conducted a randomized double-blind phase II trial of metformin 500 mg TID or placebo in non-diabetic patients with biochemically-relapsed or advanced prostate cancer (PC) due for ADT.
“To test these hypotheses, we conducted a phase II randomized, placebo-controlled, prospective study of metformin vs. placebo in patients with advanced, castrate sensitive PC treated with ADT (NCT:01620593).”
Fasting serum glucose, insulin, PSA, metformin, weight, and waist circumference (WC) were measured at baseline, week 12 and 28. The primary endpoint was a group of MS metrics. Secondary endpoints include PSA response, safety, serum metformin concentrations and analysis of downstream an mTOR target, phospho-S6-kinase.
Thirty-six men were randomized to either metformin or placebo. Mean age was 68.4. Mean weight, WC and insulin levels increased in both arms. At week 12 and 28, no statistical differences in weight, WC or insulin were observed in either arm. No significant difference in percentage of patients with PSA <0.2 at week 28 between metformin (45.5%) vs. placebo (46.7%). Analysis in the metformin-arm showed variable down-regulation of phospho-S6 kinase.
“In our small study, metformin added to ADT did not show a reduced risk of ADT-related MS or differences in PSA response.”
Read the full paper: DOI: https://doi.org/10.18632/oncotarget.28458
Correspondence to: Devalingam Mahalingam - Email: mahalingam@northwestern.edu
Keywords: prostate cancer, metformin, metastatic, androgen deprivation therapy, clinical trial
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
Sign up for free Altmetric alerts about this article: https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28458
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
Recent U.S. elections have raised the question of whether “microtargeting,” the use of extensive online data to tailor persuasive messages to voters, has altered the playing field of politics.
Now, a newly-published study led by MIT scholars finds that while targeting is effective in some political contexts, the “micro” part of things may not be the game-changing tool some have assumed.
“In a traditional messaging context where you have one issue you’re trying ...
The missing link has just been found between the earliest dinosaurs, whose size ranged from a few centimeters to at most 3 meters in length, and more recent giants that could be more than twice the length of a bus and have so much appeal to the popular imagination.
Macrocollum itaquii, buried 225 million years ago in what is now Agudo, a town in Rio Grande do Sul state, South Brazil, is the oldest dinosaur studied hitherto with structures called air sacs.
These bone cavities, which persist in present-day ...
RIVERSIDE, Calif. -- Alternative splicing, a clever way a cell generates many different variations of messenger RNAs — single-stranded RNAs involved in protein synthesis — and proteins from the same stretch of DNA, plays an important role in molecular biology. Progressing rapidly, the field of alternative splicing is a complex topic and the scientific literature on it is already extensive.
David Nikom, a student in the UC Riverside Neuroscience Graduate Program, and his advisor, Sika Zheng, an associate professor of biomedical sciences in the UCR School of Medicine and director of the Center ...
American Geophysical Union
Release No. 23-26
20 June 2023
For Immediate Release
This press release and accompanying multimedia are available here: https://news.agu.org/press-release/tongas-hunga-eruption-produced-the-most-intense-lightning-ever-recorded/
Additional study highlights:
The 15 January eruption lasted at least 11 hours, several hours longer than previously known
The plume produced the highest-altitude lightning flashes ever measured, 20 to 30 kilometers (12 to 19 miles) above sea level
Lightning “surfed” giant waves that rippled through volcanic plume
Lightning data ...
It is a scary fact that one in two women and one in three men in the United States will develop some form of cancer in their lifetime. One of the hallmarks of many cancers is the occurrence of errors during the cell division process called mitosis. Therefore, critical to enhancing treatments or perhaps even finding a cure for cancer and other diseases, is developing a better understanding of how mitosis works in both healthy and diseased cells.
Rensselaer Polytechnic Institute’s Scott Forth, Ph.D., assistant professor of biological sciences ...
During the pandemic, contact tracing apps kept Americans informed of potential exposure risk with the goal of reducing infections. But did apps like this help reduce the spread of COVID and how might we improve these apps for use in future outbreaks?
Contact tracing is a pivotal part of pandemic preparedness. Evidence-based research on best practices for contact tracing is important because when employed inefficiently contact tracing drains resources. Used effectively, contact tracing slows the spread of disease and saves lives. In the past, contact tracing was done through health ...
Prevention Strategies received a grant from the National Institutes of Health to pursue the study and develop a commercially viable intervention tool based on prevention science. Known as WorkWell, it is a tailored mobile health app that represents the next generation of evidence-based, technology-aided intervention programs.
The initial pilot program to test the WorkWell app will focus on construction trade workers and nurses, as well as nursing assistants and technicians. These occupations have been disproportionately impacted by the opioid crisis and have high mortality ratios.
“Opioid-involved overdoses are among the leading causes of death in the United States despite extensive ...
A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.
The survival rate of pancreatic adenocarcinoma, or pancreatic cancer, remains low, around 10%, because of its poor response to current chemotherapies.
The five-year grant will continue the established six-year clinical and translational research collaboration between Jennifer Bailey-Lundberg, ...
UTHSC researchers working to find new treatments to combat breast cancer metastasis recently pulled in a major national award. Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, and Tiffany Seagroves, PhD, professor of Pathology in the College of Medicine, are principal investigators on a $3.07 million grant from the National Cancer Institute for a project to develop a new series of drugs targeting microtubules to stop the spread of breast cancer to the brain and bone. Duane Miller, PhD, professor emeritus, and Zhongzhi Wu, PhD, assistant professor, both in ...
A total solar eclipse will darken a swath of North America as the Moon blocks the light of the Sun for a few minutes on April 8, 2024. In addition to casting a breathtaking, passing shadow over the heads of millions of people, this total solar eclipse gives scientists a unique opportunity to study the Sun, Earth, and their interactions.
NASA will fund five interdisciplinary science projects for the 2024 eclipse to make the most of this opportunity. The projects, which are led by researchers at different academic institutions, will study the Sun and its influence on Earth with a variety of instruments, including cameras aboard high-altitude research planes, ham radios, and ...
